Quick Answer
RAPID MICRO BIOSYSTEMS, INC. reported R&D Expense of $13.60 million for fiscal year 2025.
RAPID MICRO BIOSYSTEMS, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $13.60M | -6.8% |
| 2024 | $14.60M | +13.9% |
| 2023 | $12.82M | -0.4% |
| 2022 | $12.87M | +31.5% |
| 2021 | $9.78M | +49.8% |
| 2020 | $6.53M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.53M | -2.2% | +9.3% |
| June 30, 2025 | $3.23M | -13.7% | -10.9% |
| March 31, 2025 | $3.62M | -5.7% | +0.4% |
| September 30, 2024 | $3.61M | +15.8% | -3.6% |
| June 30, 2024 | $3.74M | +15.8% | -2.6% |
| March 31, 2024 | $3.84M | +21.9% | +23.3% |
| September 30, 2023 | $3.12M | +4.8% | -3.6% |
| June 30, 2023 | $3.23M | +9.0% | +2.5% |
- RAPID MICRO BIOSYSTEMS, INC. showed a decrease of -6.8% in R&D Expense compared to the prior fiscal year.
- Over the 2020–2025 period, RAPID MICRO BIOSYSTEMS, INC.’s r&d expense has grown by 108.3% (from $6.53 million to $13.60 million).
- The most recent figure is from RAPID MICRO BIOSYSTEMS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: